World, Newsdeck Biopharma industry eyes 2025 bounceback, grapples with uncertainty over Trump return by: Reuters
Maverick Citizen A dose of their own medicine — should SA force big drugmakers to let others make insulin pens too? by: Christina Pitt
South Africa, World, Maverick Citizen, DM168, Maverick News Doctors Without Borders calls on big pharma to continue supply of insulin pens as contract ends by: Estelle Ellis
Maverick Life The rise of Ozempic: how surprise discoveries and lizard venom led to a new class of weight-loss drugs by: Sebastian Furness
Business Maverick, South Africa, Maverick News Aspen’s Novo Nordisk deal a ‘feather in our cap’ and an NCD battle boost - top executive by: Georgina Crouth
South Africa, Maverick Citizen Aspen’s Covid vaccine facility in Gqeberha switches to making insulin for Africa by: Estelle Ellis
South Africa, Maverick Citizen Global stocks of diabetes drug Ozempic drained by doctors prescribing it for weight loss by: Zano Kunene